Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP3862085B2 - Preservation method of microorganisms and animal-derived materials - Google Patents
[go: Go Back, main page]

JP3862085B2 - Preservation method of microorganisms and animal-derived materials - Google Patents

Preservation method of microorganisms and animal-derived materials Download PDF

Info

Publication number
JP3862085B2
JP3862085B2 JP2003396325A JP2003396325A JP3862085B2 JP 3862085 B2 JP3862085 B2 JP 3862085B2 JP 2003396325 A JP2003396325 A JP 2003396325A JP 2003396325 A JP2003396325 A JP 2003396325A JP 3862085 B2 JP3862085 B2 JP 3862085B2
Authority
JP
Japan
Prior art keywords
voltage
preservation
storage
solution
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2003396325A
Other languages
Japanese (ja)
Other versions
JP2005112839A (en
Inventor
同文 林
友貴 西山
島田光生
聡 大社
明彦 三谷
Original Assignee
メビックス株式会社
株式会社フィールテクノロジー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メビックス株式会社, 株式会社フィールテクノロジー filed Critical メビックス株式会社
Priority to JP2003396325A priority Critical patent/JP3862085B2/en
Publication of JP2005112839A publication Critical patent/JP2005112839A/en
Application granted granted Critical
Publication of JP3862085B2 publication Critical patent/JP3862085B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

本発明は、微生物及び動物由来物の新規な保存方法に関する。さらに、詳しくは、微生物及び動物由来物を静電場雰囲気内におくことを特徴とする保存方法に関する。   The present invention relates to a novel method for preserving microorganisms and animal products. More specifically, the present invention relates to a storage method characterized in that microorganisms and animal-derived substances are placed in an electrostatic field atmosphere.

脳死ドナーからの肝移植は末期肝疾患に対する治療法として確立され、欧米ではすでに年間8,000例以上行なわれている。わが国でもようやく1997年に臓器移植法が施行されたが、6年を経過した2003年10月現在、脳死者からの肝提供による肝移植はわずか23例に過ぎない。一方、我が国では身内または配偶者から肝提供をうける生体部分肝移植が1989年に初めて施行されて以来、現在までに2300例以上が実施され、生体肝移植はいまや日常の診療となりつつある。   Liver transplantation from brain-dead donors has been established as a treatment for end-stage liver disease, and more than 8,000 cases have already been performed annually in the United States and Europe. In Japan, the organ transplantation law was finally enforced in 1997, but as of October 2003, six years have passed, only 23 cases of liver transplantation by donating liver from brain dead. On the other hand, in Japan, since partial living donor liver transplantation, which was donated to the liver by relatives or spouses, was first implemented in 1989, more than 2300 cases have been carried out to date, and living donor liver transplantation is now becoming a daily practice.

ドナー手術と同時進行可能で、最短の冷保存が可能な生体肝移植と異なり、脳死肝移植の場合、長時間の冷保存(0〜4℃)が不可避である。1980年代後半にUniversity of Wisconsin (UW) 液が開発され、冷保存時間の限界が従来の7〜8時間より24時間に大幅に延長し、肝移植は緊急手術より準緊急・待機手術へと変貌を遂げた。しかし現在でも5〜10%の症例に移植後グラフト機能不全がみられ、実際には16時間を超える保存ではグラフト機能不全が起こる確率が非常に高くなる。また心臓・肺移植では保存の限界はいまだに6〜7時間であり緊急手術の域を出ていないのが現状である。そこで保存時間のさらなる延長が可能であれば、その各種臓器移植に及ぼす世界的な影響ははかりしれないほど大きいと考えられる。   Unlike living donor liver transplantation, which can proceed simultaneously with donor surgery and can be stored in the shortest possible cold storage, long-term cold storage (0 to 4 ° C.) is unavoidable in the case of brain dead liver transplantation. The University of Wisconsin (UW) fluid was developed in the late 1980s, and the limit of cold storage time was greatly extended to 24 hours from the previous 7-8 hours, and liver transplantation changed from emergency surgery to quasi-emergency / waiting surgery. Has been achieved. However, even after 5 to 10% of cases, graft dysfunction is observed after transplantation, and in reality, the probability of graft dysfunction is very high when stored for more than 16 hours. In addition, the limit of preservation for heart / lung transplantation is still 6 to 7 hours, and the current situation is that it is not out of emergency surgery. Therefore, if the storage time can be further extended, the global impact on various organ transplants is considered to be so large.

臓器保存の温度に注目すれば従来の冷保存温度である4℃では代謝は1/10になり、−4℃では1/17になることが知られ、氷点下非凍結保存の有用性が示唆されていた。従来、非凍結剤を用いた実験が行われてきたが、氷点下非凍結保存は可能であるものの、非凍結剤によるグラフト障害がさけられなかった。   Focusing on organ preservation temperature, it is known that metabolism is 1/10 at the conventional cold preservation temperature of 4 ° C and 1/17 at -4 ° C, suggesting the usefulness of non-freezing non-freezing preservation. It was. Conventionally, experiments using non-freezing agents have been carried out. However, although non-freezing storage can be performed below freezing point, grafting troubles caused by non-freezing agents have not been avoided.

移植技術の発達により、移植対象の動物の組織等の保存方法の改良は種々検討されている。組織を凍結させない条件での保存は、組織がより自然に近い状態にあるため好ましい保存方法である。たとえば、グルコースを含む第一液で血管内の血液を排除かつ置換し、ジメチルスルフォキシドまたはグリセリンとマンニットを含む第二液で第一液を置換した後、凍結させずに0℃ないし20℃で保存する方法が開示されている(特許文献1)。あるいは非還元二糖と充填剤との保存剤の組み合わせによる生存微生物、細胞、または組織の保存方法の提案もある(特許文献2)。しかし、いずれの保存方法も、安定剤の添加や複雑な処理が必要であり、早期の改良が望まれている。   Due to the development of transplant technology, various improvements in the preservation method of tissues of animals to be transplanted have been studied. Storage under conditions where the tissue is not frozen is a preferred storage method because the tissue is in a more natural state. For example, blood in a blood vessel is removed and replaced with a first solution containing glucose, and the first solution is replaced with a second solution containing dimethyl sulfoxide or glycerin and mannitol. A method of storing at 0 ° C. is disclosed (Patent Document 1). There is also a proposal of a method for preserving viable microorganisms, cells, or tissues by a combination of preservatives of non-reducing disaccharides and fillers (Patent Document 2). However, any storage method requires addition of a stabilizer and complicated treatment, and early improvement is desired.

食品等を静電場雰囲気を利用して過冷却状態において保存するための装置は、本件発明者の一によって開発されている(特許文献3〜7)。しかし、それらはいずれも食品の分野でのみ利用されていたにすぎない。   An apparatus for storing food or the like in a supercooled state using an electrostatic field atmosphere has been developed by one of the inventors (Patent Documents 3 to 7). However, they were all used only in the food field.

特開平8−325101号公報JP-A-8-325101 特表2003−505024号公報Special Table 2003-505024 特開平10−136882号公報JP-A-10-136882 特開平11−332464号公報JP-A-11-332464 特開2000−297976号公報JP 2000-297976 A 特開2001−241824号公報Japanese Patent Laid-Open No. 2001-241824 国際公開WO98/41115号公報International Publication No. WO 98/41115

微生物及び動物由来物の新規な保存方法の提供が、本発明の課題である。   It is an object of the present invention to provide a novel method for preserving microorganisms and animal origin.

上記課題を解決するために鋭意検討した結果、本発明者らは、微生物又は動物由来物を静電場雰囲気におくことで微生物及び動物由来物をより自然な形で保存しうることを見出し、本発明を完成した。
つまり本発明は以下からなる。
1.動物由来物である赤血球を静電場雰囲気内におき、0℃〜4℃の温度条件で保存する保存方法。
2.保存液中に浸漬状態である、動物由来物である心臓、肝臓、あるいは腎臓を静電場雰囲気内におき、以下の条件下で保存する保存方法。
心臓:−5℃〜2℃の温度条件
肝臓:−5℃〜2℃の温度条件
腎臓:−5℃〜0℃の温度条件
3.前記静電場雰囲気は、100V〜5000Vの交流又は直流電圧を電極に印加して形成される前項1または2に記載の保存方法。
As a result of intensive studies to solve the above problems, the present inventors have found that microorganisms and animal-derived materials can be preserved in a more natural form by placing microorganisms or animal-derived materials in an electrostatic field atmosphere. Completed the invention.
That is, this invention consists of the following.
1. A storage method in which red blood cells derived from animals are placed in an electrostatic field atmosphere and stored under a temperature condition of 0 ° C to 4 ° C.
2. A preservation method in which an animal-derived heart, liver, or kidney that is immersed in a preservation solution is placed in an electrostatic field atmosphere and preserved under the following conditions.
2. Heart: -5 ° C to 2 ° C temperature condition Liver: -5 ° C to 2 ° C temperature condition Kidney: -5 ° C to 0 ° C temperature condition 3. The storage method according to item 1 or 2, wherein the electrostatic field atmosphere is formed by applying an AC or DC voltage of 100 V to 5000 V to the electrode.

本発明の静電場雰囲気に器官や臓器等を保存することにより、組織等を損傷することなく長期保存することが可能となる。すなわち、本発明の方法では微生物又は動物由来物を長期間の間自然に近い状態で、微生物または動物由来物が有する活性を不活化若しくは不活性化させることなく、又は死滅化させることなく保存することができる。   By storing organs or organs in the electrostatic field atmosphere of the present invention, it is possible to store them for a long time without damaging the tissues or the like. That is, in the method of the present invention, the microorganism or animal-derived material is stored in a state close to nature for a long period of time without inactivating or inactivating the activity of the microorganism or animal-derived material or killing it. be able to.

臓器保存においては、氷点下非凍結保存により代謝が押さえられること、抗酸化作用により再灌流時の酸化ストレスを押さえ虚血再灌流障害を軽減する可能性がある。臓器を静電場雰囲気に置き微振動のエネルギーを与えることで、通常では凍結してしまう温度、例えば−5℃程度であっても、器官や臓器等が凍結するのを防ぎ、損傷することなく長期保存することが可能となる。   In organ preservation, there is a possibility that metabolism is suppressed by non-freezing preservation below freezing and that oxidative stress at the time of reperfusion is suppressed by antioxidative action to reduce ischemia-reperfusion injury. By placing the organ in an electrostatic field atmosphere and applying micro-vibration energy, it is possible to prevent the organ or the organ from freezing at a temperature that would normally freeze, for example, about -5 ° C, and prevent damage for a long time without damage. It can be saved.

本発明の静電場雰囲気とは、例えば閉鎖系又は開放系の容器内を静電場状態にすることをいう。電場雰囲気とするために、種々の手段が公知であるが、例えば容器内の底部に単に電極板を絶縁状態で載置することにより静電場状態にすることができる。また、通常の家庭用又は業務用の冷蔵庫を簡便に静電場冷蔵庫に変換することができる。例えば絶縁材料(塩ビ板)からなる横板と、この横板の両側にヒンジを介して組立て自在とされた側板と、電場箱の底部を閉塞する底板から形成される。そして、その前面と上面は開放されて冷蔵庫の扉を開いたときに対象物の出入が容易に行ない得る。接続線、高電圧発生装置で、高電圧がいずれかの金属棒等に印加され、静電場が形成される。   The electrostatic field atmosphere of the present invention refers to, for example, bringing a closed or open container into an electrostatic field state. Various means are known in order to obtain an electric field atmosphere. For example, the electrode plate can be brought into an electrostatic state by simply placing the electrode plate in an insulated state on the bottom of the container. Moreover, a normal household or commercial refrigerator can be easily converted into an electrostatic field refrigerator. For example, it is formed of a horizontal plate made of an insulating material (vinyl chloride plate), side plates that can be assembled to both sides of the horizontal plate via hinges, and a bottom plate that closes the bottom of the electric field box. And when the front and upper surfaces are opened and the refrigerator door is opened, the object can be easily put in and out. A high voltage is applied to one of the metal bars or the like by a connecting line or a high voltage generator to form an electrostatic field.

本発明の微生物又は動物由来細胞の保存方法に使用することができる保存装置として、具体的には、静電場雰囲気を形成させるための電極を備えた容器と、該電極に交流または直流電圧を印加する静電場発生用電源と、上記容器に、例えば動物の臓器を冷蔵温度に保持できる冷却装置とを備えた装置を例示することができる。   As a storage device that can be used in the method for storing a microorganism or animal-derived cell of the present invention, specifically, a container equipped with an electrode for forming an electrostatic field atmosphere, and an AC or DC voltage is applied to the electrode Examples of the apparatus include an electrostatic field generating power source and a cooling device capable of maintaining an organ of an animal at a refrigerated temperature, for example.

更に、冷蔵室内の空気を帯電させるためには、導電性カーテンを設けてもよく、このカーテンは柔軟な布、プラスチック等の表面に導電性塗料を付着せしめたり、カーテン自体を薄いアルミ板等にすることにより形成してもよい。そして、カーテンは、レール等を介して高電圧発生装置に接続される。   Furthermore, in order to charge the air in the refrigeration room, a conductive curtain may be provided. This curtain is made by attaching a conductive paint to the surface of a flexible cloth or plastic, or the curtain itself is made of a thin aluminum plate or the like. You may form by doing. The curtain is connected to the high voltage generator via a rail or the like.

本発明の静電場雰囲気は、100V〜5000V、好ましくは100V〜3000Vの交流又は直流電圧を電極に印加して形成される。印加する電圧は、保存対象物やその保存状態により適宜選択することができる。特に、保存液中で保存する場合や保存容器の材質により、印加する電圧を選択することができる。電流は交流、直流のいずれであってもよい。   The electrostatic field atmosphere of the present invention is formed by applying an AC or DC voltage of 100 V to 5000 V, preferably 100 V to 3000 V, to the electrodes. The voltage to be applied can be appropriately selected depending on the storage object and its storage state. In particular, the voltage to be applied can be selected in the case of storing in a storage solution or depending on the material of the storage container. The current may be either alternating current or direct current.

本発明の静電場雰囲気におく保存方法に適用されうる温度は、−20〜40℃、好ましくは−20〜5℃、より好ましくは−12〜−1℃、さらに好ましくは−5〜−1℃である。保存する温度は、保存対象物やその保存状態により適宜選択することができる。特に例えば0℃以下であっても、過冷却現象により、保存対象物を凍結させることなく保存することができる。ここに過冷却現象とは、液体が凍り始める寸前の温度である氷結点を下回る温度であっても物質が凍らない現象をいう。氷結点を下回る温度の場合でも、本発明の静電場雰囲気下では、物質へ温度を伝えると同時に微振動エネルギーが起こり、水溶液は凍結せず、微生物及び動物由来物の凍結もおこらないと考えられる。   The temperature that can be applied to the storage method in the electrostatic field atmosphere of the present invention is -20 to 40 ° C, preferably -20 to 5 ° C, more preferably -12 to -1 ° C, and further preferably -5 to -1 ° C. It is. The temperature to preserve | save can be suitably selected with a preservation | save object and its preservation | save state. In particular, even when the temperature is 0 ° C. or lower, the object to be stored can be stored without freezing due to the supercooling phenomenon. Here, the supercooling phenomenon refers to a phenomenon in which a substance does not freeze even at a temperature below the freezing point, which is the temperature just before the liquid begins to freeze. Even when the temperature is below the freezing point, in the electrostatic field atmosphere of the present invention, it is considered that microvibration energy occurs at the same time that the temperature is transmitted to the substance, the aqueous solution does not freeze, and the microorganisms and animal-derived substances do not freeze. .

微生物又は動物由来物が保存液中に浸漬状態であるとは、微生物及び動物由来物が金属やプラスチック等の容器内の保存液中に浸っている状態をいい、一般的に公知のあらゆる細胞等の保存液や今後開発される保存液を利用することができる。保存液の代表的なものとして、例えば今日の移植(Vol.11, No.5, September p.549-557(1998))に例示されるリンゲル液、ユーロコリンズ溶液、UW溶液、SLS溶液、H−L溶液、HTK溶液等や、市販品、例えばラクテック(大塚製薬製)が挙げられる。   The microorganism or animal-derived material being immersed in the preservation solution means a state where the microorganism or animal-derived material is immersed in the preservation solution in a container such as metal or plastic, and any generally known cells, etc. Can be used as well as future storage solutions. As typical preservation solutions, for example, Ringer's solution, Eurocollins solution, UW solution, SLS solution, H-- exemplified in today's transplantation (Vol.11, No.5, September p.549-557 (1998)). Examples include L solution, HTK solution and the like, and commercially available products such as Lactec (manufactured by Otsuka Pharmaceutical).

微生物又は動物由来物が、静電場雰囲気中にそのまま存置されるとは、微生物又は動物由来物が、水溶液中におかれることなくそのまま静電場雰囲気中におかれることをいい、物質そのものが金属やプラスチック等の容器内に収納されて保存されていても良い。例えば、微生物を静電場雰囲気中にそのまま存置すると、過冷却現象により仮死状態とすることができ、精製蛋白質であれば、そのまま安定に不活化の心配なく長期保存することが可能である。また、採血した血液やその由来物を、CPD液(クエン酸ナトリウム、クエン酸、グルコース、NaH2PO4・2H2Oを含む)やMAP液(マンニトール、アデニン、リン酸を含む)等を含むプラスチック(pp)製等の採血用バッグに入れて、静電場雰囲気中にそのまま存置すると、例えば0℃以上でも安定に保存することができる。 The term “microorganism or animal-derived substance is left as it is in an electrostatic field atmosphere” means that the microorganism or animal-derived substance is left in an electrostatic field atmosphere without being placed in an aqueous solution. It may be stored in a container such as plastic. For example, if microorganisms are left as they are in an electrostatic field atmosphere, they can be put into a dead state due to a supercooling phenomenon, and a purified protein can be stored as it is for a long time without worrying about inactivation. In addition, collected blood and its derivatives include CPD solution (including sodium citrate, citrate, glucose, NaH 2 PO 4 · 2H 2 O), MAP solution (including mannitol, adenine, and phosphate). When placed in a blood collection bag made of plastic (pp) or the like and left as it is in an electrostatic field atmosphere, it can be stably stored, for example, at 0 ° C. or higher.

かくして、本発明の方法は、移植領域での臓器・組織保存、輸血領域での血液成分保存、生物由来製剤領域での成分保存、血漿分画製剤の保存、再生医療領域での細胞・組織保存、基礎実験領域での各種培養細胞保存、遺伝子治療領域での遺伝子および薬剤を導入したベクターの保存、臨床検査領域での検体保存、製薬・試薬領域での精製蛋白質保存等の領域で適用することができる。   Thus, the method of the present invention comprises organ / tissue preservation in the transplant area, blood component preservation in the transfusion area, ingredient preservation in the biological preparation area, preservation of the plasma fraction preparation, cell / tissue preservation in the regenerative medicine area. Application in areas such as storage of various cultured cells in the basic experimental area, storage of genes and drugs introduced in the gene therapy area, specimen storage in the clinical laboratory area, and storage of purified protein in the pharmaceutical / reagent area Can do.

本発明の保存方法に適用される微生物及び動物由来物は、細菌、真菌類、ウイルス等の微生物、ヒト及びヒト以外の動物由来の物質を含むことを意味し、例えば移植領域での臓器・組織では、心臓、肺、肝臓、腎臓、膵臓、小腸、心臓弁、皮膚、血管、角膜、眼球、硬膜、骨、気管、耳小骨等が、輸血領域での血液成分では、血小板、白血球、赤血球、さい帯血、血漿各成分、各種因子等が、生物由来製剤領域での成分では、血液や尿成分由来の精製蛋白質、例えば血液凝固因子、抗凝固因子、トロンビン、ウロキナーゼ、ウリナスタチン、プラセンタやこれらの遺伝子組換蛋白質、その他ゼラチン、へパリン、コンドロイチン、ヒアルロン酸等が、再生医療領域での細胞・組織では、造血幹細胞、ES細胞(胚性幹細胞)、骨髄、各種因子等が、臨床検査領域での検体では、生化学検体、内分泌検体、ウイルス検体、細菌検体、真菌検体、免疫血清検体、細胞性免疫検体、遺伝子、染色体検体、染色体検体、血液学検体、微生物検体、病理学検体等が、遺伝子治療領域では遺伝子および薬剤を導入したベクターを含む微生物が、基礎実験領域での各種培養細胞では、血管内皮細胞、血液幹細胞、再生医療用各種細胞等を挙げることができる。   Microorganisms and animal-derived materials applied to the preservation method of the present invention mean that they include microorganisms such as bacteria, fungi, and viruses, and substances derived from humans and animals other than humans. The heart, lung, liver, kidney, pancreas, small intestine, heart valve, skin, blood vessel, cornea, eyeball, dura mater, bone, trachea, ear ossicle, etc. , Umbilical cord blood, plasma components, various factors, etc., in the biological product area, purified proteins derived from blood and urine components such as blood coagulation factor, anticoagulation factor, thrombin, urokinase, ulinastatin, placenta and these Recombinant proteins, other gelatins, heparin, chondroitin, hyaluronic acid, etc. are hematopoietic stem cells, ES cells (embryonic stem cells), bone marrow, various factors However, biochemical samples, endocrine samples, virus samples, bacterial samples, fungal samples, immune serum samples, cellular immune samples, genes, chromosome samples, chromosome samples, hematology samples, microbial samples, Pathological specimens, etc. include microorganisms containing vectors and genes introduced in gene therapy areas, and various cultured cells in basic experimental areas include vascular endothelial cells, blood stem cells, various cells for regenerative medicine, etc. .

以下に実施例で本発明を説明するが、これらは本発明の典型的代表例を示すものであって、本発明はこれらに限定されるものではない。   EXAMPLES The present invention will be described below with reference to examples, but these show typical representative examples of the present invention, and the present invention is not limited thereto.

(実施例1)腎臓
1)腎臓の摘出及び保存
ラット成獣を麻酔し、四肢を18G針で固定し、ラットの胸から腹にかけて開腹した。横隔膜直下で大動脈をクランプし、下大静脈・肝静脈を併せクランプし、その遠位部を開窓し、紙ワイパーを挿入した。該ラットの左腎静脈の背側に大動脈を同定し、ラクテック(大塚製薬製)5mLで腎臓をゆっくり灌流した。
該ラットの左右の腎臓を摘出し、ラクテック(大塚製薬製)を含むデッシュに置いた。腎臓片に注射針を用いて4mLの保存液を注入し、各保存条件で保存した。
2)腎臓の保存
1回目:4℃で電圧を印加しない場合及び−5℃で500V,1000Vの各電圧を印加した条件下で、28時間保存した。
2回目:0℃電圧を印加しない場合及び−3℃で100Vの電圧を印加した条件下で、各々28.5時間及び67時間保存した。
3)結果
上記保存条件下で保存したときの液中に漏出した乳酸脱水素酵素(l-lactate dehydrogenase、以下「LDH」)を測定した。さらに、2回目には腎臓組織切片を染色し、光学顕微鏡にて観察した。その結果を表1及び表2に示した。個体差は認められたものの、電圧をかけない場合よりも電圧をかけた場合のほうが保存溶液に漏出したLDHの値は低値であり、いずれの場合も良好な結果を示した。また、2回目の28.5時間保存後の組織片は、電圧をかけない場合では変性所見が観察されたが、電圧をかけた場合には明らかな変性は観察されなかった。

Figure 0003862085




Figure 0003862085
(Example 1) Kidney 1) Removal and preservation of kidney An adult rat was anesthetized, the limbs were fixed with an 18G needle, and the abdomen was opened from the chest of the rat to the abdomen. The aorta was clamped directly under the diaphragm, the inferior vena cava and hepatic vein were clamped together, the distal part thereof was opened, and a paper wiper was inserted. The aorta was identified on the dorsal side of the left renal vein of the rat, and the kidney was slowly perfused with 5 mL of Lactec (manufactured by Otsuka Pharmaceutical).
The right and left kidneys of the rat were removed and placed in a dish containing Lactec (manufactured by Otsuka Pharmaceutical). 4 mL of the preservation solution was injected into the kidney piece using an injection needle and preserved under each preservation condition.
2) Preservation of kidney 1st time: When the voltage was not applied at 4 ° C. and under the condition that each voltage of 500 V and 1000 V was applied at −5 ° C., the kidney was stored for 28 hours.
Second time: The sample was stored for 28.5 hours and 67 hours under the condition that no voltage was applied at 0 ° C and a voltage of 100 V was applied at -3 ° C.
3) Results Lactic acid dehydrogenase (l-lactate dehydrogenase, hereinafter referred to as “LDH”) leaked into the liquid when stored under the above storage conditions was measured. Furthermore, at the second time, kidney tissue sections were stained and observed with an optical microscope. The results are shown in Tables 1 and 2. Although individual differences were observed, the value of LDH leaked into the storage solution was lower when a voltage was applied than when no voltage was applied, and good results were obtained in all cases. In addition, the tissue pieces after the 2nd storage for 28.5 hours were observed to denature when no voltage was applied, but no obvious degeneration was observed when the voltage was applied.
Figure 0003862085




Figure 0003862085

(実施例2)肝臓
1)肝臓の摘出
ラット成獣を麻酔し、四肢を18G針で固定し、ラットの胸から腹にかけて開腹した。門脈からUW液(今日の移植:Vol.11, No.5, September p.549-557(1998))4mLをゆっくり注入し、肝臓を灌流・摘出し、UW液を含むデッシュに置き、臓器保存した。摘出した肝臓片に注射針を用いて10mLの保存液を注入し、各保存条件で冷蔵した。
2)肝臓の保存
4℃で電圧を印加しない場合及び−5℃で500V,1000Vの各電圧を印加した条件下で、肝臓を4時間保存した。
3)結果
各条件下で保存したときの保存液内に漏出したグルタミン酸−オキサロ酢酸トランスアミナーゼ(glutamic-oxaloacetic transaminase、以下「GOT」),グルタミン酸−ピルビン酸トランスアミナーゼ(glutamic-pyruvic transaminase、以下「GPT」),LDHの測定結果を表3に示した。その結果、500Vの電圧を印加した条件下で保存した場合に最も良好な結果が得られた。

Figure 0003862085
(Example 2) Liver 1) Extraction of Liver An adult rat was anesthetized, the limbs were fixed with an 18G needle, and the abdomen was opened from the chest of the rat to the abdomen. Slowly inject 4 mL of UW fluid from the portal vein (today's transplant: Vol.11, No.5, September p.549-557 (1998)), perfuse and extract the liver, place it in a dish containing UW fluid, and organ saved. 10 mL of a preservative solution was injected into the extracted liver piece using an injection needle and refrigerated under each storage condition.
2) Liver preservation The liver was preserved for 4 hours under the conditions where no voltage was applied at 4 ° C and each voltage of 500 V and 1000 V was applied at -5 ° C.
3) Results Glutamate-oxaloacetic transaminase (hereinafter referred to as “GOT”), glutamic acid-pyruvic transaminase (hereinafter referred to as “GPT”) leaked into the preservation solution when stored under each condition. Table 3 shows the measurement results of LDH. As a result, the best results were obtained when stored under conditions where a voltage of 500 V was applied.
Figure 0003862085

(実施例3)心臓
1)心臓の摘出及び保存
ラット成獣を麻酔し、四肢を18G針で固定し、ラットの胸から腹にかけて開胸した。心臓を大血管と共に速やかに摘出し、ラクテック(大塚製薬製)を含むデッシュ(6cm)に置き、臓器保存した。
自律心拍により、保存した心臓の心腔内はラクテック(大塚製薬製)に置換された。
心臓片に注射針を用いて4mLの保存液を注入し、各保存条件で冷蔵した。
2)心臓の保存
4℃で電圧を印加しない場合及び−5℃で500V,1000Vの各電圧を印加した条件下で、心臓を4時間保存したときの保存液内のGOT,GPT,LDHを測定した。また、組織切片を染色し、光学顕微鏡にて観察した。
3)結果
各条件下で保存したときの保存液内に漏出したクレアチンキナーゼ(creatine kinase,以下「CK」),GOT,及びLDHの測定結果を表4に示した。その結果、電圧を印加しない場合よりも印加したときのほうが、保存溶液に漏出したCK,GOT,及びLDHの値は低値であり、良好な結果を示した。心筋組織は、各条件において細胞質及び核ともに明らかな変化は認められず、良好であった。

Figure 0003862085
(Example 3) Heart 1) Extraction and preservation of heart An adult rat was anesthetized, the limbs were fixed with an 18G needle, and the thoracotomy was performed from the chest to the abdomen of the rat. The heart was quickly removed together with the large blood vessel, placed in a dish (6 cm) containing Lactec (manufactured by Otsuka Pharmaceutical), and the organ was preserved.
The heart chamber of the preserved heart was replaced with Lactec (manufactured by Otsuka Pharmaceutical Co., Ltd.) by the autonomous heartbeat.
4 mL of the preservation solution was injected into the heart piece using an injection needle and refrigerated under each preservation condition.
2) Preservation of the heart GOT, GPT, LDH in the preservation solution is measured when the heart is stored for 4 hours under the condition that no voltage is applied at 4 ° C and each voltage of 500V and 1000V is applied at -5 ° C. did. In addition, tissue sections were stained and observed with an optical microscope.
3) Results Table 4 shows the measurement results of creatine kinase (creatine kinase, hereinafter referred to as “CK”), GOT, and LDH leaked into the storage solution when stored under each condition. As a result, the values of CK, GOT, and LDH leaked into the storage solution were lower when the voltage was applied than when no voltage was applied, indicating a good result. Myocardial tissue was good with no obvious changes in cytoplasm and nucleus in each condition.
Figure 0003862085

(実施例4)赤血球
1)赤血球の取得
自己輸血のために術前貯血式自己輸血する方法により採血した。採血した血液を通常行う遠心分離により赤血球と血漿に分離し、MAP液で保存した赤血球溶液をpp採血用バックに保存した。
2)赤血球の保存
該MAP赤血球溶液を、2mLずつプラスチック製試験管チューブに分注し、4℃で、電圧を印加しない非電場群及び3000Vの電圧を印加した電場群の条件で保存した。
3)結果
該MAP赤血球溶液を各条件下で保存したときの保存状態を観察し、その結果を表5及び表6に示した。保存後7日目でも電圧印加しない場合よりも印加した場合のほうがpHの変化及びカリウム(K)の漏出度の変化が少なく、保存条件として良好であることが確認された(表5)。さらに、保存後15日であっても、電圧印加しない場合よりも印加した場合のほうがカリウム(K)の漏出度が少なく、ナトリウム(Na)量の変化も少なく、保存条件として良好であることが確認された(表6)。

Figure 0003862085



Figure 0003862085
(Example 4) Red blood cells 1) Acquisition of red blood cells Blood was collected by a preoperative blood storage type self-transfusion method for self-transfusion. The collected blood was separated into red blood cells and plasma by a conventional centrifugation, and the red blood cell solution stored in the MAP solution was stored in a pp blood collection bag.
2) Storage of red blood cells The MAP red blood cell solution was dispensed in 2 mL aliquots into plastic test tube tubes, and stored at 4 ° C under the conditions of a non-electric field group to which no voltage was applied and an electric field group to which a voltage of 3000 V was applied.
3) Results The storage state when the MAP erythrocyte solution was stored under each condition was observed, and the results are shown in Tables 5 and 6. Even when the voltage was not applied even on the seventh day after storage, it was confirmed that the change in pH and the change in the degree of leakage of potassium (K) were less and the storage conditions were better (Table 5). Furthermore, even after 15 days of storage, the leakage of potassium (K) and the change in the amount of sodium (Na) are less when the voltage is applied than when no voltage is applied, and the storage conditions are good. It was confirmed (Table 6).
Figure 0003862085



Figure 0003862085

(実施例5)心臓片
1)心臓の摘出及び保存
ラット雄成獣をエーテル麻酔し、四肢を18G針で固定し、腹から頚にかけて左右に開腹した。肝臓の上縁を横隔膜から切離し横隔膜を穿孔して開胸した。横隔膜前縁を左右に開腹した後、胸骨に沿って両側の肋骨を切断した。下行大動脈をクランプし、臓器心筋保護液ラクテックG(大塚製薬製)を5mL注入し、下行大動脈近位部に心筋保護液ミオテクター(日清製油製)を3mL注入し、心臓を摘出し、ミオテクターを含むデッシュに置き、臓器保存した。
2)心臓の保存
18G針で4mLの心筋保護液を心臓に注入し、軽く揺らしてから2℃で電圧を印加しない場合及び100V,500Vの各電圧を印加した条件下で保存した。
3)結果
各条件下で保存したときの心筋保護液内に漏出したクレアチンホスホキナーゼ(creatin phospho kinase、以下「CPK」),GOT,LDHの測定結果を表7に示した。対照として保存1時間後についても測定した。24時間保存後、印加しない場合に比べて電圧を印加したほうがCPK、GOT及びLDHの漏出が低く抑えられる傾向が認められた。

Figure 0003862085
(Example 5) Heart segment 1) Extraction and preservation of heart An adult male rat was anesthetized with ether, the limbs were fixed with an 18G needle, and the abdomen was opened from side to side to the neck. The upper edge of the liver was cut off from the diaphragm and the diaphragm was perforated to open the thoracotomy. After opening the front edge of the diaphragm to the left and right, the ribs on both sides were cut along the sternum. Clamp the descending aorta, inject 5 mL of organ myocardial protective fluid Lactec G (manufactured by Otsuka Pharmaceutical), inject 3 mL of myocardial protective fluid myo- tector (manufactured by Nissin Oil) into the proximal part of the descending aorta, remove the heart, Placed in a dish containing and preserved organs.
2) Preservation of the heart 4 mL of myocardial protective solution was injected into the heart with an 18G needle, shaken gently, and then stored under the conditions where no voltage was applied at 2 ° C. and each voltage of 100 V and 500 V was applied.
3) Results Table 7 shows the measurement results of creatine phosphokinase (creatin phospho kinase, hereinafter referred to as “CPK”), GOT, and LDH leaked into the myocardial protective solution when stored under each condition. As a control, it was also measured after 1 hour of storage. After storage for 24 hours, leakage of CPK, GOT and LDH tended to be kept lower when voltage was applied than when no voltage was applied.
Figure 0003862085

(実施例6)肝臓
1)肝臓の摘出及び保存
実施例5で心臓が摘出された後のラットの下大動脈のクランプをはずし、門脈のなるべく遠位から臓器保存液ビアスパン(藤沢薬品工業製)4mLをゆっくり注入し、肝臓を摘出し、ビアスパンを加えたデッシュに置き、臓器保存した。
2)肝臓の保存
18G針で10mLの保存液を肝臓に注入し、軽く揺らしてから2℃で電圧を印加しない場合及び100V,500Vの各電圧を印加した条件下で保存した。
3)結果
各条件下で保存したときの保存液内に漏出したGOT,GPT,LDH,γGPT,アルカリホスファターゼ(alkaline phosphatase、以下「ALP」)の測定結果を表8に示した。対照として保存1時間後についても測定した。その結果、24時間保存後では対照に比べてGOT,GPT,LDH及びALPは増加の傾向が認められた。印加しない場合に比べて、電圧印加の条件下で保存したほうが、GOT,GPT及びLDHの漏出が低く抑えられる傾向が認められた。

Figure 0003862085
(Example 6) Liver 1) Extraction and preservation of liver After the heart was removed in Example 5, the rat lower aorta was clamped, and the organ preservation solution beer span (from Fujisawa Pharmaceutical Co., Ltd.) as far as possible from the portal vein. 4 mL was slowly injected, the liver was removed, placed in a dish containing beer span, and preserved in organs.
2) Preservation of the liver 10 mL of the preservative solution was injected into the liver with an 18G needle, shaken gently, and stored under the conditions where no voltage was applied at 2 ° C. and each voltage of 100 V and 500 V was applied.
3) Results Table 8 shows the measurement results of GOT, GPT, LDH, γGPT, and alkaline phosphatase (hereinafter referred to as “ALP”) leaked into the storage solution when stored under each condition. As a control, it was also measured after 1 hour of storage. As a result, GOT, GPT, LDH and ALP tended to increase after storage for 24 hours compared to the control. It was recognized that leakage of GOT, GPT and LDH tended to be kept lower when stored under voltage application conditions than when no voltage was applied.
Figure 0003862085

(実施例7)心臓片
1)心臓の摘出及び保存
ラット雄成獣をエーテル麻酔し、四肢を18G針で固定し、腹から頚にかけて皮切をおいて左右に開腹した。肝臓の上縁を横隔膜から切離し横隔膜を穿孔して開胸した。横隔膜前縁を左右に開腹した後、下行大動脈をクランプし、臓器保存液ラクテックG(大塚製薬製)を5mL注入し、下行大動脈近位部に心筋保護液ミオテクター(日清製油製)を3mL注入し、心臓を摘出し、ミオテクターを含むデッシュに置き、臓器保存した。
2)心臓の保存
18G針で4mLの保存液を心臓に注入し、軽く揺らしてから0℃で電圧を印加しない場合及び100V、500Vの各電圧を印加した条件下で、心臓を保存した。
3)結果
各条件下で保存したときの保存液内に漏出したCPKの測定結果を表9に示した。対照として保存開始30分についても測定した。その結果、4時間後では、対照に比べてCPK値はほとんど増加しなかった。24時間保存後では、印加しない場合はCPK値が増加していたが、電圧を印加条件下で保存すると低く抑えられる傾向が認められた。







Figure 0003862085
(Example 7) Heart fragment 1) Extraction and preservation of heart An adult rat male was anesthetized with ether, the limbs were fixed with an 18G needle, the skin was cut from the abdomen to the neck, and the abdomen was opened left and right. The upper edge of the liver was cut off from the diaphragm and the diaphragm was perforated to open the thoracotomy. After opening the front edge of the diaphragm to the left and right, the descending aorta is clamped, 5 mL of organ preservation solution Lactec G (manufactured by Otsuka Pharmaceutical) is injected, and 3 mL of myocardial protective fluid myo- tector (manufactured by Nisshin Oil) is injected into the proximal part of the descending aorta. Then, the heart was removed, placed in a dish containing a myocector, and preserved in organs.
2) Preservation of the heart 4 mL of preservative solution was injected into the heart with an 18G needle, and the heart was preserved under the condition where no voltage was applied at 0 ° C. after applying light shaking and under the conditions of applying 100 V and 500 V voltages.
3) Results Table 9 shows the measurement results of CPK leaked into the storage solution when stored under each condition. As a control, measurement was also performed for 30 minutes from the start of storage. As a result, after 4 hours, the CPK value hardly increased compared to the control. After 24 hours of storage, the CPK value increased when no voltage was applied, but a tendency to be kept low when the voltage was stored under the applied conditions was observed.







Figure 0003862085

(実施例8)肝臓
1)肝臓の摘出及び保存
実施例7で心臓が摘出された後のラットの下大動脈のクランプをはずし、門脈のなるべく遠位から臓器保存液ビアスパン(藤沢薬品工業製)4mLをゆっくり注入し、肝臓を摘出し、ビアスパンを加えたデッシュに置き、臓器保存した。
2)肝臓の保存
18G針で10mLの保存液を肝臓に注入し、軽く揺らしてから0℃で電圧を印加しない場合及び100V,500Vの各電圧を印加した条件下で保存した。
3)結果
各条件下で保存したときの保存液内に漏出したGOT,GPT,LDH,ALPの測定結果を表10に示した。対照として、保存30分後についても測定した。その結果、肝臓保存後24時間ではGOT,GPT,LDH及びALPは増加の傾向が認められたが、印加しない場合に比べて、電圧を印加した条件で保存したほうが、各物質の漏出が低く抑えられる傾向が認められた。

Figure 0003862085
(Example 8) Liver 1) Extraction and preservation of liver After the heart was removed in Example 7, the rat lower aorta was unclamped, and the organ preservation solution beer span (made by Fujisawa Pharmaceutical Co., Ltd.) from the distal end of the portal vein as much as possible. 4 mL was slowly injected, the liver was removed, placed in a dish containing beer span, and preserved in organs.
2) Preservation of liver 10 mL of the preservative solution was injected into the liver with an 18G needle and shaken gently, and then stored under the conditions where no voltage was applied at 0 ° C. and each voltage of 100 V and 500 V was applied.
3) Results Table 10 shows the measurement results of GOT, GPT, LDH, and ALP leaked into the storage solution when stored under each condition. As a control, measurement was also performed after 30 minutes of storage. As a result, GOT, GPT, LDH, and ALP tended to increase 24 hours after liver preservation, but the leakage of each substance was kept lower when stored under conditions where voltage was applied than when not applied. A tendency was observed.
Figure 0003862085

(実施例)腎臓
1)肝臓の摘出及び保存
実施例9で肝臓が摘出された後のラットから左右の腎臓を順次摘出し、ラクテック(大塚製薬製)を加えたデッシュに置き、臓器保存した。
2)腎臓の保存
18G針で4mLの保存液を腎臓に注入し、軽く揺らしてから0℃で電圧を印加しない場合及び100V,500Vの各電圧を印加した条件下で保存した。
3)結果
各条件下で保存したときの保存液内に漏出したGOT及びLDHの測定結果を表11に示した。対照として、保存30分後についても測定した。その結果、23時間及び69時間保存後ではGOT及びLDHの測定値が増加の傾向が認められたが、印加しない場合に比べて、電圧を印加した条件で保存したほうが、各物質の漏出が低く抑えられる傾向が認められた。

Figure 0003862085
(Example 9 ) Kidney 1) Extraction and preservation of liver The left and right kidneys were sequentially removed from the rat after the liver was removed in Example 9, placed in a dish with Lactec (manufactured by Otsuka Pharmaceutical) and preserved in organs. .
2) Preservation of kidney 4 mL of the preservative solution was injected into the kidney with an 18G needle, shaken gently, and stored under the conditions where no voltage was applied at 0 ° C. and each voltage of 100 V and 500 V was applied.
3) Results Table 11 shows the measurement results of GOT and LDH leaked into the storage solution when stored under each condition. As a control, measurement was also performed after 30 minutes of storage. As a result, the measured values of GOT and LDH tended to increase after storage for 23 hours and 69 hours, but the leakage of each substance was lower when stored under the condition of applying voltage than when not applied. A tendency to be suppressed was observed.
Figure 0003862085

(実施例10)心臓
1)心臓の摘出及び保存
ラット雄成獣をエーテル麻酔し、四肢を18G針で固定し、腹から頚にかけて皮切をおいて左右に開腹した。肝臓の上縁を横隔膜から切離し横隔膜を穿孔して開胸した。横隔膜前縁を左右に開腹した後、下行大動脈をクランプし、臓器保存液ラクテックG(大塚製薬製)を5mL注入し、下行大動脈近位部に心筋保護液ミオテクター(日清製油製)を3mL注入し、心臓を摘出し、ミオテクターを含むデッシュに置き、臓器保存した。
(Example 10) Heart 1) Extraction and preservation of heart An adult rat male was anesthetized with ether, the limbs were fixed with an 18G needle, and the skin was cut from the abdomen to the neck. The upper edge of the liver was cut off from the diaphragm and the diaphragm was perforated to open the thoracotomy. After opening the front edge of the diaphragm to the left and right, the descending aorta is clamped, 5 mL of organ preservation solution Lactec G (manufactured by Otsuka Pharmaceutical) is injected, and 3 mL of myocardial protective fluid myo- tector (manufactured by Nisshin Oil) is injected into the proximal part of the descending aorta. Then, the heart was removed, placed in a dish containing a myocector, and preserved in organs.

2)心臓の保存
18G針で4mLの保存液を心臓に注入し、軽く揺らしてから0℃で電圧を印加しない場合及び100V、500Vの各電圧を印加した条件下で、心臓を保存した。
2) Preservation of the heart 4 mL of preservative solution was injected into the heart with an 18G needle, and the heart was preserved under the condition where no voltage was applied at 0 ° C. after applying light shaking and under the conditions of applying 100 V and 500 V voltages.

3)CK−MBの測定
免疫阻止−UV法により測定する。具体的には、次の方法による。上記の保存条件にて心臓を保存したときの保存液中のCK−Mサブユニットのみを特異的に阻害する抗体を用い、CK−Bサブユニットの活性を測定する。その値を2倍することにより、CK−MBの活性を求めることができる。
3) Measurement of CK-MB Measured by immunosuppression-UV method. Specifically, the following method is used. The activity of the CK-B subunit is measured using an antibody that specifically inhibits only the CK-M subunit in the preservation solution when the heart is preserved under the above preservation conditions. By doubling the value, the activity of CK-MB can be determined.

4)トロポニンTの測定
免疫化学発光免疫測定法(ECLIA)により測定する。本法は電気化学発反応を用いたステップサンドイッチ法である。検体内のトロポニンTとビオチン化抗トロポニンT抗体をよびRu(bpy)3 2+標識抗トロポニンT抗体を反応させ、標識抗体−トロポニンT−ビオチン化抗体複合物を生成させる。次にストレプトアビジン(SA)をコーティングした磁性マイクロパーティクル(MP)を加えてアビジン−ビオチン反応をさせる。反応終了後、混合溶液を測定セル内に吸引し、電極の磁力により磁性マイクロパーティクルを電極に引き付ける。電気供与物質である、トリプロアミン(TPA)にてB/F分離を行い、電極による酸化反応とTPAラジカルの還元作用により生じるRu2+錯体からの発光量を測定し、トロポニンT量を測定する。
4) Measurement of troponin T Measured by immunochemiluminescence immunoassay (ECLIA). This method is a step sandwich method using an electro-chemiluminescent reactions. The troponin T in the sample is reacted with the biotinylated anti-troponin T antibody and Ru (bpy) 3 2+ labeled anti-troponin T antibody to produce a labeled antibody-troponin T-biotinylated antibody complex. Next, magnetic microparticles (MP) coated with streptavidin (SA) are added to cause avidin-biotin reaction. After completion of the reaction, the mixed solution is sucked into the measurement cell, and the magnetic microparticles are attracted to the electrode by the magnetic force of the electrode. B / F separation is performed with triproamine (TPA), which is an electrical donor, and the amount of luminescence from the Ru 2+ complex generated by the oxidation reaction by the electrode and the reduction action of the TPA radical is measured, and the amount of troponin T is measured. .

5)結果
各条件下で保存したときの保存液内に漏出したCK−MBの測定結果を図1に、心筋トロポニンの測定結果を図2に示した。対照として保存開始30分についても測定した。その結果、24時間保存後では印加しない場合に比べて電圧を印加条件下で保存したほうが、これらの測定値が低く抑えられ、印加電圧が100Vよりも500Vの方が良好な結果を示した。
5) Results FIG. 1 shows the measurement results of CK-MB leaked into the preservation solution when stored under each condition, and FIG. 2 shows the measurement results of cardiac troponin. As a control, measurement was also performed for 30 minutes from the start of storage. As a result, these measured values were kept lower when the voltage was stored under the applied condition than when no voltage was applied after 24 hours of storage, and a better result was obtained when the applied voltage was 500V than 100V.

(実施例11)赤血球
1)赤血球の取得
自己輸血のために術前貯血式自己輸血する方法により採血した。採血した血液を通常行う遠心分離により赤血球と血漿に分離し、MAP液で保存した赤血球溶液をpp採血用バックに保存した。
2)赤血球の保存
該MAP赤血球溶液を、2mLずつプラスチック製試験管チューブに分注し、電圧を印加しない非電場群及び500Vの電圧を印加した電場群について各々4℃で保存した。
3)結果
各条件で保存したときのナトリウム(Na)、カリウム(K)、遊離ヘモグロビン(遊離Hb)、総ハプトグロビン(総Hp)を測定し、その結果を表12〜15に示した。保存時間経過に伴い、Naは減少傾向を認め、K及び遊離Hpは増加傾向を認めた。Na、K及び総Hpについては非電場群と電場群ではほとんど差を認めなかったが、遊離Hbは非電場群に比べて電場群のほうが増加抑制効果が認められた。

Figure 0003862085


Figure 0003862085
Figure 0003862085
Figure 0003862085
(Example 11) Red blood cells 1) Acquisition of red blood cells For self-transfusion, blood was collected by a preoperative blood storage type self-transfusion method. The collected blood was separated into red blood cells and plasma by a conventional centrifugation, and the red blood cell solution stored in the MAP solution was stored in a pp blood collection bag.
2) Storage of erythrocytes The MAP erythrocyte solution was dispensed in 2 mL aliquots into plastic test tube tubes, and stored at 4 ° C. for each of a non-electric field group to which no voltage was applied and an electric field group to which a voltage of 500 V was applied.
3) Results Sodium (Na), potassium (K), free hemoglobin (free Hb), and total haptoglobin (total Hp) when stored under each condition were measured, and the results are shown in Tables 12-15. As the storage time passed, Na decreased, and K and free Hp increased. Regarding Na, K, and total Hp, there was almost no difference between the non-electric field group and the electric field group, but free Hb was more effective to suppress the increase in the electric field group than in the non-electric field group.
Figure 0003862085


Figure 0003862085
Figure 0003862085
Figure 0003862085

(実施例12)赤血球
1)赤血球の取得
自己輸血のために術前貯血式自己輸血する方法により採血した。採血した血液を通常行う遠心分離により赤血球と血漿に分離し、MAP液で保存した赤血球溶液をpp採血用バックに保存した。
2)赤血球の保存
該MAP赤血球溶液を、2mLずつプラスチック製試験管チューブに分注し、電圧を印加しない非電場群及び3000Vの電圧を印加した電場群について各々4℃で保存した。
3)結果
各条件で保存したときのNa、K、遊離Hb、総Hpを測定し、その結果を表16〜19に示した。保存時間経過に伴い非電場群ではNaは減少傾向を認め、K及び遊離Hbは増加傾向を認めたが、電場群ではNaの減少は抑制され、K及び遊離Hbの増加傾向についても抑制が認められた。

Figure 0003862085
Figure 0003862085
Figure 0003862085
Figure 0003862085
(Example 12) Red blood cells 1) Acquisition of red blood cells For self-transfusion, blood was collected by a preoperative blood storage type self-transfusion method. The collected blood was separated into red blood cells and plasma by a conventional centrifugation, and the red blood cell solution stored in the MAP solution was stored in a pp blood collection bag.
2) Storage of erythrocytes The MAP erythrocyte solution was dispensed at 2 mL into plastic test tube tubes, and stored at 4 ° C. for each of a non-electric field group to which no voltage was applied and an electric field group to which a voltage of 3000 V was applied.
3) Results Na, K, free Hb, and total Hp when stored under each condition were measured, and the results are shown in Tables 16-19. In the non-electric field group, Na decreased in the non-electric field group and K and free Hb increased, but the decrease in Na was suppressed in the non-electric field group, and the increase in K and free Hb was also suppressed. It was.
Figure 0003862085
Figure 0003862085
Figure 0003862085
Figure 0003862085

(実施例13)肝臓
A)温度条件の検討
−4℃,−5℃,−6℃の温度で臓器保存液(UW液)に100V,500V,1000V,2000V,3000Vの電圧印加を行い、UW液が氷結しない条件を設定した。 その結果、電圧を印加したときは−4℃で凍結しないことが確認された。
B)電圧印加条件(4℃0V,−4℃、100V)
ラットの肝臓を摘出し、−4℃にて電圧を100Vを印加してUW液中で24時間保存した群のAST,ALT,及びLDHを測定した。4℃で電圧を印加しない条件を対照群とした。
その結果を図3に示した。対照群に比べ、−4℃にて電圧を100Vを印加したときの方がAST,ALT,及びLDHのすべてについて低値を示し、良好であった。
C)電圧印加条件(4℃0V,4℃、3000V)
ラットの肝臓を摘出し、4℃にて電圧を3000Vを印加してUW液中で24時間保存した群のAST,ALT,及びLDHを測定した。4℃で電圧を印加しない条件を対照群とした。
その結果を図4に示した。対照群及び電圧を印加群の間にAST,ALT,及びLDHの有効な差異は認められなかった。
(Example 13) Liver A) Examination of temperature conditions Voltages of 100V, 500V, 1000V, 2000V, 3000V were applied to organ preservation solution (UW solution) at temperatures of -4 ° C, -5 ° C, -6 ° C, and UW Conditions were set so that the liquid did not freeze. As a result, it was confirmed that when the voltage was applied, it did not freeze at -4 ° C.
B) Voltage application conditions (4 ° C 0V, -4 ° C, 100V)
Rat livers were removed, and AST, ALT, and LDH were measured in a group that was stored in UW solution for 24 hours by applying a voltage of 100 V at -4 ° C. A condition where no voltage was applied at 4 ° C. was taken as a control group.
The results are shown in FIG. Compared with the control group, when volt was applied at −4 ° C. with a voltage of 100 V, all of AST, ALT, and LDH showed lower values and were better.
C) Voltage application conditions (4 ° C 0V, 4 ° C, 3000V)
Rat livers were removed, and AST, ALT, and LDH were measured in a group stored at 4 ° C. with a voltage of 3000 V and stored in UW solution for 24 hours. A condition where no voltage was applied at 4 ° C. was taken as a control group.
The results are shown in FIG. There were no effective differences in AST, ALT, and LDH between the control and voltage applied groups.

以上説明したように、本発明の静電場雰囲気下におくと、0℃以下であっても微生物又は動物由来物、例えば、器官や臓器等を凍結させることなく保存することができ、0℃以上の場合であっても血液等について良好な状態で保存することができた。つまり、本発明の静電場雰囲気下による保存方法を適用することで、従来よりも長期間の間、微生物又は動物由来物を自然に近い状態で保存することが可能となり、特に移植領域、輸血領域、再生医療領域、基礎実験領域、遺伝子治療領域、臨床検査領域、製薬・試薬領域等に利用することができる。   As described above, when placed in an electrostatic field atmosphere of the present invention, microorganisms or animal-derived materials such as organs and organs can be stored without freezing even at 0 ° C. or lower, and 0 ° C. or higher. Even in this case, blood and the like could be stored in a good state. In other words, by applying the preservation method under the electrostatic field atmosphere of the present invention, it becomes possible to preserve microorganisms or animal-derived substances in a state close to nature for a longer period of time than before, particularly in transplantation regions and transfusion regions. It can be used for regenerative medicine, basic experiment, gene therapy, clinical testing, pharmaceutical / reagent, etc.

心臓を電圧印加条件下で保存したときの保存液中のCK−MBを測定した結果を示す図である。(実施例10)It is a figure which shows the result of having measured CK-MB in a preservation | save liquid when the heart is preserve | saved under voltage application conditions. (Example 10) 心臓を電圧印加条件下で保存したときの保存液中のトロポニンTを測定した結果を示す図である。(実施例10)It is a figure which shows the result of having measured the troponin T in a preservation | save liquid when the heart is preserve | saved under voltage application conditions. (Example 10) 肝臓を100Vの電圧印加条件下で保存したときの保存液中のAST、ALT及びLDHを測定した結果を示す図である。(実施例13)It is a figure which shows the result of having measured AST, ALT, and LDH in a preservation | save liquid when the liver was preserve | saved under the voltage application conditions of 100V. (Example 13) 肝臓を3000Vの電圧印加条件下で保存したときの保存液中のAST、ALT及びLDHを測定した結果を示す図である。(実施例13)It is a figure which shows the result of having measured AST, ALT, and LDH in a preservation | save liquid when the liver was preserve | saved on the voltage application conditions of 3000V. (Example 13)

Claims (3)

動物由来物である赤血球を静電場雰囲気内におき、0℃〜4℃の温度条件で保存する保存方法。 A storage method in which red blood cells derived from animals are placed in an electrostatic field atmosphere and stored under a temperature condition of 0 ° C to 4 ° C. 保存液中に浸漬状態である、動物由来物である心臓、肝臓、あるいは腎臓を静電場雰囲気内におき、以下の条件下で保存する保存方法。
心臓:−5℃〜2℃の温度条件
肝臓:−5℃〜2℃の温度条件
腎臓:−5℃〜0℃の温度条件
A preservation method in which an animal-derived heart, liver, or kidney that is immersed in a preservation solution is placed in an electrostatic field atmosphere and preserved under the following conditions.
Heart: -5 ° C to 2 ° C temperature condition Liver: -5 ° C to 2 ° C temperature condition Kidney: -5 ° C to 0 ° C temperature condition
前記静電場雰囲気は、100V〜5000Vの交流又は直流電圧を電極に印加して形成される請求項1または2に記載の保存方法。 The storage method according to claim 1 or 2, wherein the electrostatic field atmosphere is formed by applying an AC or DC voltage of 100V to 5000V to the electrodes.
JP2003396325A 2003-09-19 2003-11-26 Preservation method of microorganisms and animal-derived materials Expired - Lifetime JP3862085B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003396325A JP3862085B2 (en) 2003-09-19 2003-11-26 Preservation method of microorganisms and animal-derived materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003327247 2003-09-19
JP2003396325A JP3862085B2 (en) 2003-09-19 2003-11-26 Preservation method of microorganisms and animal-derived materials

Publications (2)

Publication Number Publication Date
JP2005112839A JP2005112839A (en) 2005-04-28
JP3862085B2 true JP3862085B2 (en) 2006-12-27

Family

ID=34554604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003396325A Expired - Lifetime JP3862085B2 (en) 2003-09-19 2003-11-26 Preservation method of microorganisms and animal-derived materials

Country Status (1)

Country Link
JP (1) JP3862085B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06001587A (en) 2003-08-11 2006-08-25 Yugengaisha Sun World Kawamura METHOD AND APPARATUS FOR FOOD PRESERVATION.
JP2007295802A (en) * 2004-07-23 2007-11-15 Mebix Kk Preservation method of microorganisms and animal-derived materials
WO2006085534A1 (en) * 2005-02-08 2006-08-17 Mebix.Inc. Method of activating the function of cells for transplantation
JP2006230257A (en) * 2005-02-23 2006-09-07 Feel Technology Co Ltd How to use a sub-freezing electrostatic field device
JP4965125B2 (en) * 2005-12-31 2012-07-04 国立大学法人高知大学 Biomaterial storage method
JP2008092842A (en) * 2006-10-11 2008-04-24 Feel Technology Co Ltd Method for preserving material to be preserved
JP2009007296A (en) 2007-06-28 2009-01-15 Kochi Univ Biomaterial storage method
CN101726575A (en) * 2008-10-16 2010-06-09 魏胜非 Method for using high-voltage static to activate luminescent microorganisms to detect acute poison in drinking water
JP6095149B2 (en) * 2009-04-12 2017-03-15 有限会社 サンワールド川村 How to store food
JP5458446B2 (en) * 2012-01-27 2014-04-02 国立大学法人高知大学 Biomaterial storage method
JP2016039792A (en) * 2014-08-13 2016-03-24 学校法人関西医科大学 Method for preserving biological tissue or cells
JP2025094837A (en) * 2023-12-13 2025-06-25 国立大学法人京都大学 Method for producing frozen cells

Also Published As

Publication number Publication date
JP2005112839A (en) 2005-04-28

Similar Documents

Publication Publication Date Title
JP3862085B2 (en) Preservation method of microorganisms and animal-derived materials
DE10138564B4 (en) Method of devitalizing natural organs and / or providing extracellular matrices for tissue engineering
JP6636956B2 (en) Human liver scaffold
JP6336392B2 (en) Long-term maintenance method of organ or tissue for transplantation
CN103074298B (en) A kind of Human fat mesenchymal stem cell bank and construction process thereof
US8198085B2 (en) Somatic cells for use in cell therapy
Seo et al. Cryopreservation of amniotic fluid-derived stem cells using natural cryoprotectants and low concentrations of dimethylsulfoxide
Kanias et al. Mammalian cell desiccation: facing the challenges
CN107711823B (en) A kind of cell cryopreservation solution stored at room temperature and its application
CN101247720B (en) cell storage medium
AU2025230792A1 (en) Oxygenation media for ex-vivo preservation of organs and tissues
CN108812643B (en) Preparation and cryopreservation method and application of human placental chorionic villus tissue
JP2007295802A (en) Preservation method of microorganisms and animal-derived materials
WO2006100740A1 (en) Method for storage of substances originated from microorganism and animal
CN115968863A (en) Menstrual blood preservative fluid and cryopreservation method of menstrual blood stem cells
US11998002B2 (en) Cryopreserving processes
JP2006217832A (en) Apparatus for preserving cell or the like
JP6412696B2 (en) Serum preparation method and instrument
KR102868680B1 (en) Composition for preserving isolated cells, tissues, or organs containing an isolated mitochondria and use thereof
JP2010248160A (en) Peptide with cell life extension effect
JP3186881B2 (en) Hepatocyte isolation method
US20250197814A1 (en) Method for preserving cells
Mara et al. Using decellularized malabar nightshade (Basella Alba L.) leaves as biomimetic scaffolds functionalized for engineering cardiac tissues
Mangan Development and Implementation of Ice Recrystallization Inhibitors for the Preservation of Biological Material
US20210317415A1 (en) Perfusion system for harvesting bone marrow

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060426

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060807

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060830

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060920

R150 Certificate of patent or registration of utility model

Ref document number: 3862085

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101006

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131006

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131006

Year of fee payment: 7

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131006

Year of fee payment: 7

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131006

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term